Osaka, Japan

Yasuo Yamamoto

This inventor holds 17 USPTO granted patents and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Mitsubishi Tanabe Pharma Corporation, Allied Corporation, Daihen Corporation. Active years: 1985-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuo Yamamoto. Retrieved from https://idiyas.com/inventor/yasuo-yamamoto-2oyccskw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 82.4


Average Co-Inventor Count = 3.8

ph-index = 8

Forward Citations = 196(Granted Patents)


Location History:

  • Settsu, JP (1986 - 1987)
  • Osaka, JP (1985 - 2019)

Company Filing History:


Years Active: 1985-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
Melanocortin Receptor Agonists
Nitrogen-Containing Compounds
Mineralocorticoid Receptor
Indole Derivatives
Fiber Reinforced Plastics
Window Glass
Electrical Induction Apparatus
Transformer Cores
Reinforced Plastic Molding
Optical Fiber
17 patents (USPTO):Explore Patents

Title: Yasuo Yamamoto: Innovator in Melanocortin Receptor Agonists

Introduction

Yasuo Yamamoto is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act as melanocortin receptor agonists. With a total of 17 patents to his name, his work has the potential to impact medical treatments significantly.

Latest Patents

Yasuo Yamamoto's latest patents include innovative compounds that demonstrate melanocortin receptor agonistic activity. One of his notable inventions is a substituted imidazole compound, which is described as having a unique structure that allows it to interact effectively with melanocortin receptors. This compound, along with its pharmaceutically acceptable salts, opens new avenues for medical applications. Another significant patent involves a pyrrolidine compound, which also exhibits melanocortin receptor agonist activity. This compound is characterized by its complex structure, which includes various substituents that enhance its pharmaceutical potential.

Career Highlights

Throughout his career, Yasuo Yamamoto has worked with reputable companies in the pharmaceutical industry. He has been associated with Mitsubishi Tanabe Pharma Corporation and Daihen Corporation, where he has contributed to research and development efforts. His expertise in medicinal chemistry and pharmacology has been instrumental in advancing the understanding of melanocortin receptors.

Collaborations

Yasuo Yamamoto has collaborated with notable colleagues in his field, including Katsumi Hanaoka and Masatake Hirai. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical compounds.

Conclusion

Yasuo Yamamoto's contributions to the field of pharmaceuticals, particularly in the area of melanocortin receptor agonists, highlight his role as a leading inventor. His extensive patent portfolio and collaborations with industry professionals underscore his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…